PKDL Development after Combination Treatment with Miltefosine and Paromomycin in a Case of Visceral Leishmaniasis: First Ever Case Report
Priya Krishna, Jorge Alvar(Real Academia Española), Pradeep Das(Rajendra Memorial Research Institute of Medical Sciences), Vishal Goyal(Chandigarh University), Neena Verma(Rajendra Memorial Research Institute of Medical Sciences), Suman Rijal(Nepal Cancer Hospital and Research Center), Rabi Das, Nand Ravi Das Vidya, ey(Chhatrapati Shahu Ji Maharaj University)
Unknown
January 1, 2018
Cited by 3
Related Papers
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
|Clinical Microbiology Reviews|2018|218
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
|PLoS neglected tropical diseases|2017|78
Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis
|BMC Public Health|2017|72